Article info
PDFPostScript
Letter
Q351R MAPT mutation is associated with a mixed 3R/4R tauopathy and a slowly progressive cognitive, behavioural and parkinsonian syndrome
- Correspondence to Dr Jonathan Daniel Rohrer, Department of Neurodegenerative Disease, University College London, London, WC1N 3BG, UK; j.rohrer{at}ucl.ac.uk
Citation
Q351R MAPT mutation is associated with a mixed 3R/4R tauopathy and a slowly progressive cognitive, behavioural and parkinsonian syndrome
Publication history
- Received March 30, 2022
- Accepted August 19, 2022
- First published October 13, 2022.
Online issue publication
January 11, 2023
Article Versions
- Previous version (13 October 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.